Cimetidine — sold as Tagamet, and as Tagamet HB over the counter — was the first H2 blocker ever made, and the first drug in history to earn a billion dollars a year. It still works, it’s still on pharmacy shelves, and no, it has not been banned. The drug people are thinking of when they ask that is ranitidine (Zantac), which is a different molecule with a different problem.
What’s true is that cimetidine has been quietly demoted. Famotidine does the same job with a fraction of the drug interactions and none of the hormonal side effects, so cimetidine is rarely anyone’s first pick for reflux any more. That doesn’t make it useless — it makes it a drug you should choose deliberately rather than by accident.
Here’s what it does, how it compares, the side effects and interactions that pushed it down the list, and the specific situations where I think it still has something to offer someone dealing with reflux.
Key Takeaways
- Cimetidine is not banned. It remains available on prescription and over the counter — the withdrawn drug was ranitidine (Zantac), pulled in 2020 over NDMA contamination.
- FDA testing found no NDMA in cimetidine, famotidine or lansoprazole.
- It’s an H2 blocker: it blocks histamine at the stomach’s H2 receptors, reducing acid output within about an hour — faster than a PPI, but less completely.
- Typical OTC dose is 200–400 mg for heartburn; the prescription dose for reflux esophagitis is 1,600 mg daily in divided doses for up to 12 weeks.
- Tolerance develops fast — measurable by the second dose — which is why H2 blockers suit occasional use far better than daily use.
- For healing erosive esophagitis, H2 blockers reach about 52% healing against about 84% for PPIs.
- Cimetidine’s real drawback is drug interactions: it inhibits CYP1A2, CYP2C9, CYP2D6 and CYP3A4, affecting warfarin, phenytoin, theophylline, beta blockers and more.
- It’s the only H2 blocker with antiandrogenic effects — gynecomastia occurs in roughly 0.3–1% of ordinary use, rising to about 4% at high doses.
Why Is Cimetidine Banned? (It Isn’t)
This question gets searched constantly, and it comes from a genuine mix-up worth clearing up properly.
In April 2020, the FDA requested that manufacturers withdraw all prescription and over-the-counter ranitidine products — Zantac and its generics — from the market immediately. The reason was NDMA, a probable human carcinogen, which testing showed can build up in ranitidine over time and at higher storage temperatures. Crucially, the same testing program found no NDMA in famotidine, cimetidine or lansoprazole [FDA, Drug Safety Communication, 2020].
So cimetidine survived the event that removed its closest competitor. If you’ve read that “the H2 blocker was banned,” that’s ranitidine. Cimetidine’s decline is a different story — it lost out on merit, not safety recalls, and the reasons are the interactions and side effects further down this page.
How Cimetidine Works
Acid-producing cells in the stomach lining respond to three signals: histamine, gastrin and acetylcholine. Cimetidine competitively blocks histamine at the H2 receptor, which turns down both daytime and night-time acid secretion [Pino and Patel, StatPearls, 2026]. It’s a partial brake on one of three inputs, which is why it reduces acid rather than shutting it off.
That’s the key difference from a proton pump inhibitor, which disables the pump itself — the final common step for all three signals. PPIs suppress acid far more completely but take days to reach full effect and need to be timed around meals. H2 blockers work within about an hour and can be taken when you need them. Different tools for different jobs.
Worth noting for anyone who takes allergy medication: the antihistamines you buy for hay fever act on H1 receptors, not H2, so they do nothing for acid. I go through that overlap in antihistamines and acid reflux.
Cimetidine Dosing for Heartburn and Reflux
Over the counter, cimetidine is used at 200–400 mg to prevent or relieve heartburn, taken around 30 minutes before a meal you expect to cause trouble [Pino and Patel, StatPearls, 2026]. That pre-emptive use is where H2 blockers shine — a known trigger meal, a late dinner, a night out.
On prescription, the dose for reflux esophagitis is considerably higher: 1,600 mg daily in divided doses (800 mg twice daily, or 400 mg four times daily) for 12 weeks, with no established benefit beyond that [DailyMed, Cimetidine Prescribing Information]. Four doses a day is a lot of pill-taking, and that inconvenience is part of why the drug faded.
How Well Does It Actually Work for Reflux?
Honestly? Reasonably, for mild and occasional symptoms. Poorly, for anything structural.
The clearest numbers come from comparisons across the classes: H2 blockers heal about 51.9% of moderate-to-severe erosive esophagitis, against about 83.6% for PPIs, and both healing and symptom relief are measurably slower [Shibli et al., Translational Gastroenterology and Hepatology, 2025]. That review’s practical conclusion is the one I’d echo: H2 blockers are a reasonable option in low-grade erosive esophagitis or for people who can’t or won’t take a PPI, and have no real role in severe disease.
Then there’s the thing almost nobody is told at the pharmacy counter: H2 blockers lose their punch fast. A review of the tolerance data found tachyphylaxis appearing at the very first point it was measured after the initial dose — as early as the second day of dosing — across different H2 blockers, doses, and in both healthy people and reflux patients. The authors’ recommendation is to reserve H2 blockers for occasional heartburn and consider a PPI where symptoms occur twice a week or more [McRorie et al., World Journal of Gastrointestinal Pharmacology and Therapeutics, 2014].
That single fact explains an experience I hear about constantly: the tablet worked brilliantly for the first few days and then seemed to stop. It wasn’t your imagination, and it wasn’t your reflux getting worse. It’s how the drug behaves. PPIs do the opposite — they build up over several days.
Cimetidine Side Effects
For short-term use, most people have no trouble at all. The label reports headache in 3.5% of people on 1,600 mg a day (2.1% at 800 mg), with dizziness, drowsiness and diarrhea each affecting around 1 in 100 [DailyMed, Cimetidine Prescribing Information]. The issues specific to this drug are these:
- Antiandrogenic effects. Cimetidine binds androgen receptors and raises prolactin, so it can cause breast tenderness and enlargement (gynecomastia) in men, and occasionally reduced libido or erectile difficulty. The label puts gynecomastia at 0.3–1% in ordinary use, rising to about 4% in high-dose hypersecretory conditions, and it’s reversible on stopping. No other H2 blocker does this.
- Confusion and drowsiness in older adults. Cimetidine crosses into the brain, and headache, dizziness, delirium and somnolence are recognized problems in elderly patients and anyone with kidney or liver impairment. The 2023 Beers Criteria advise caution with H2 blockers in older adults because of delirium risk [Pino and Patel, StatPearls, 2026].
- Reduced B12 absorption with prolonged use, the same acid-related mechanism that affects PPI users — covered in what nutrients acid suppressants deplete.
The Drug Interaction Problem
This is the real reason cimetidine slid down the list, and it’s worth understanding rather than glossing over.
Cimetidine inhibits several major liver enzymes — CYP1A2, CYP2C9, CYP2D6 and CYP3A4 — which between them metabolize an enormous share of common medications. Blocking them means other drugs clear more slowly and their levels rise. The documented list includes warfarin (increased bleeding risk), phenytoin, theophylline, beta blockers such as metoprolol and propranolol (bradycardia and low blood pressure), tricyclic antidepressants, benzodiazepines, calcium channel blockers, lidocaine and metronidazole [Pino and Patel, StatPearls, 2026].
For someone young and on no other medication, this is mostly theoretical. For anyone on a regular prescription — and particularly for older adults, who are both more likely to be on several drugs and more sensitive to the CNS effects — it’s a genuine reason to pick something else. Famotidine has no meaningful CYP inhibition, which is precisely why it won.
Cimetidine vs Famotidine
Briefly, because the comparison isn’t close: famotidine is more potent per milligram, is taken once or twice daily rather than up to four times, doesn’t inhibit liver enzymes, and has no antiandrogenic effect. If you want an H2 blocker, famotidine is the sensible default, and it’s what I’d suggest discussing with a pharmacist first. I’ve written about the options in alternatives to famotidine and compared the classes in famotidine vs omeprazole.
Where cimetidine holds an edge is availability and price — it’s cheap, widely stocked, and occasionally the only H2 blocker on the shelf during a famotidine supply squeeze. It’s a perfectly reasonable stand-in for occasional heartburn in someone who isn’t on interacting medication.
Where an H2 Blocker Still Fits — Including in Silent Reflux
Three situations, in my view.
Pre-emptive dosing before a known trigger. Taking an H2 blocker 30–60 minutes before a meal you know will cause problems uses the drug the way it works best: fast onset, occasional use, no time for tolerance to build.
Night-time breakthrough on top of a PPI. Adding a bedtime H2 blocker to twice-daily PPI therapy is a recognized option for people with refractory symptoms [Shibli et al., Translational Gastroenterology and Hepatology, 2025]. This matters most in night-time reflux, when acid escapes for hours while you’re horizontal — though the tolerance problem means it tends to work better used intermittently than every single night.
As part of a wider LPR plan, with realistic expectations. For silent reflux, acid suppression of any kind is only half an answer — a large share of throat symptoms come from weakly acidic reflux and from pepsin that an acid-blocking drug doesn’t touch, which is why PPIs so often disappoint in LPR and why H2 blockers, being weaker, rarely do better. If you want the full menu of what does and doesn’t help, that’s in the best medications for LPR.
The common thread is that these are all cover strategies. Nothing on this page reduces how often you reflux — that comes from the mechanics: what you eat, when you eat it, and how you sleep. It’s the reason I built the Wipeout Diet Plan around reducing reflux events rather than neutralizing them after the fact.
One Note on Why Cimetidine Is Searched So Much
If cimetidine looks improbably popular for a semi-retired ulcer drug, that’s because most of the interest isn’t about heartburn at all. It has a set of off-label uses driven by its effect on immune signalling — stubborn warts, molluscum contagiosum, chronic urticaria — plus a substantial veterinary use [Pino and Patel, StatPearls, 2026]. Those are real but entirely separate from reflux, and none of them change how you’d use the drug for heartburn.
Conclusion
Cimetidine is a perfectly functional H2 blocker that history has overtaken. It isn’t banned and it isn’t dangerous in ordinary use, but it interacts with a long list of medications, carries hormonal effects no other drug in its class has, and needs dosing up to four times a day. If you want an H2 blocker, famotidine does the same job more cleanly. If you’re treating anything more than occasional heartburn, the H2 class as a whole is the wrong tool — it heals about half of what a PPI heals, and it loses effectiveness within days of regular use.
The bigger point is that no acid blocker, old or new, reduces the number of times reflux happens. It changes what the refluxate is made of and buys you comfort while the real work happens elsewhere. That’s what the Wipeout Diet Plan is for — the complete framework I put together after years of managing this myself. I built it around LPR, the stubborn throat-based form that responds worst to medication, but because it works on the same underlying mechanisms it’s just as effective for classic GERD and heartburn. Used alongside whatever medication you’re on, it’s what gives you a route off the tablets rather than a longer stay on them. If you’d rather start with something simpler, the Wipeout Food Reference Guide is the essential companion — every food and drink worth knowing about for reflux and LPR, with pH values, so you can cut your trigger load this week.
Frequently Asked Questions
Why is cimetidine banned?
It isn’t. Cimetidine is still available both on prescription and over the counter. The drug withdrawn from the market was ranitidine (Zantac), which the FDA asked manufacturers to pull in April 2020 because of NDMA contamination that increased over time and with warm storage. FDA testing found no NDMA in cimetidine or famotidine.
Is cimetidine good for heartburn?
For occasional heartburn, yes — it reduces acid within about an hour and can be taken pre-emptively before a trigger meal. For frequent or severe reflux it’s a weak choice: H2 blockers heal roughly 52% of erosive esophagitis compared with about 84% for PPIs, and tolerance to them develops within days of regular dosing.
Cimetidine vs famotidine — which is better?
Famotidine, for almost everyone. It’s more potent per milligram, needs fewer daily doses, doesn’t inhibit the liver enzymes that cause cimetidine’s long interaction list, and has no antiandrogenic effects. Cimetidine’s advantages are price and availability.
What are the main cimetidine side effects?
Headache (3.5% at the highest dose), dizziness, drowsiness and diarrhea each in about 1 in 100 people. The ones specific to cimetidine are gynecomastia and other antiandrogenic effects (0.3–1% in ordinary use, about 4% at high doses, reversible on stopping) and confusion or drowsiness in older adults and people with kidney or liver impairment.
Does cimetidine interact with other medications?
Yes, extensively. It inhibits CYP1A2, CYP2C9, CYP2D6 and CYP3A4, raising levels of warfarin, phenytoin, theophylline, beta blockers, tricyclic antidepressants, benzodiazepines, calcium channel blockers and others. Anyone on regular medication should check with a pharmacist before taking it.
Is cimetidine stronger than omeprazole?
No. Omeprazole is a proton pump inhibitor, which blocks the final step of acid production and suppresses acid far more completely and for longer. Cimetidine acts faster — useful for on-demand relief — but is weaker, shorter-acting and loses effect with repeated dosing.
How long can you take cimetidine for?
Over-the-counter use is intended for short courses of about two weeks; the prescription course for reflux esophagitis runs up to 12 weeks, with no proven benefit beyond that. Because tolerance develops quickly, taking it continuously for long periods gives diminishing returns. If you need acid suppression for months, that’s a conversation with your doctor about whether a different drug or a different strategy is appropriate.
Research & References
- [FDA, Drug Safety Communication, 2020] — April 2020 announcement requesting immediate market withdrawal of all prescription and over-the-counter ranitidine products because NDMA levels increase over time and with higher storage temperatures; FDA testing found no NDMA in famotidine, cimetidine or lansoprazole.
- [Pino and Patel, StatPearls, 2026] — Review of cimetidine covering its H2-receptor mechanism, approved and off-label uses, OTC dosing of 200–400 mg for heartburn, antiandrogenic effects and gynecomastia, CNS effects in older adults and renal impairment, and inhibition of CYP1A2, CYP2C9, CYP2D6 and CYP3A4 with the resulting interaction list.
- [DailyMed, Cimetidine Prescribing Information] — FDA label giving the reflux esophagitis regimen of 1,600 mg daily in divided doses for 12 weeks, adverse reaction rates including headache 3.5% at 1,600 mg/day and gynecomastia in 0.3–1% of general use versus about 4% in hypersecretory states, and the reduced hepatic metabolism of warfarin, phenytoin, propranolol, theophylline and others.
- [McRorie et al., World Journal of Gastrointestinal Pharmacology and Therapeutics, 2014] — Review finding tachyphylaxis to H2-receptor antagonists consistently present at the first measurement after the initial dose, including by the second day of dosing, across drugs, doses and patient groups, and recommending H2 blockers be reserved for occasional heartburn.
- [Shibli et al., Translational Gastroenterology and Hepatology, 2025] — Narrative review reporting H2-receptor antagonist healing rates of 51.9% versus 83.6% for proton pump inhibitors in moderate-to-severe reflux disease, restricting H2 blockers to low-grade erosive esophagitis, and noting bedtime H2 blocker addition to twice-daily PPI therapy as an option in refractory symptoms.
David Gray
12 years living with LPR · Consultant & researcher
I've lived with LPR for twelve years — the misdiagnoses, the PPI courses that did nothing, the slow work of figuring out what actually helps. Wipeout Reflux is where I translate the research into plain terms for people stuck in the same place. Every claim here is sourced to peer-reviewed work, and I consult one-to-one with LPR sufferers.